Cited by 18Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and TreatmentsGenetic Associations and Epidemiology

Genetics of Primary Biliary Cholangitis

Gerussi, Alessio, Asselta, Rosanna, Invernizzi, Pietro·2022·Clinics in Liver Disease

Abstract

Primary biliary cholangitis (PBC) is a rare disease of the liver characterized by an autoimmune attack on the small bile ducts. PBC is a complex trait, meaning that a large list of genetic factors interacts with environmental agents to determine its onset. Genome-wide association studies have had a huge impact in fostering research in PBC, but many steps need still to be done compared with other autoimmune diseases of similar prevalence. This review presents the state-of-the-art regarding the genetic architecture of PBC and provides some thoughtful reflections about possible future lines of research, which can be helpful to fill the missing heritability gap in PBC.

Integrity signals

Registry

Crossref · 10.1016/j.cld.2022.06.002

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Although HLA alleles exhibit the strongest association with primary biliary cholangitis, their contribution to disease risk is less than that of other autoimmune diseases.

    “Although HLA alleles exhibit the strongest association with primary biliary cholangitis, their contribution to disease risk is less than that of other autoimmune diseases.12”

    From Primary biliary cholangitis. (2024) · cites this paper as [12]

The citation lists haven’t been fetched yet

References 67 · Cited by 18

Authors
Gerussi, A., Asselta, R., & Invernizzi, P.
Affiliations
  • Azienda Ospedaliera San Gerardo (IT)
  • Humanitas University (IT)
Venue
Clinics in Liver Disease
Publisher
Elsevier BV
Published
2022-11
Volume
26
Issue
4
Pages
571-582
ISSN
1089-3261 (ISSN-L)
OpenAlex
W4295202946
Cited by
18
References
67
Citations by year
2026: 3 · 2025: 11 · 2024: 2 · 2023: 1 · 2022: 1
FWCI
0.64
Type
journal article
Language
en
Open access
closed
Locations
  • Clinics in Liver Disease (publishedVersion)
  • PubMed (publishedVersion)
  • BOA (University of Milano-Bicocca) (submittedVersion)
Topics
  • Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
  • Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
Keywords
primary biliary cirrhosis, genetic architecture, genome-wide association study, autoimmune liver disease, bile ducts, genetic susceptibility, missing heritability, complex traits, environmental factors
MeSH terms
Autoimmune Diseases, Humans, Liver Cirrhosis, Biliary, Genome-Wide Association Study

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review